Status:
NOT_YET_RECRUITING
Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies
Lead Sponsor:
Children Hospital and Institute of Child Health, Lahore
Conditions:
Scabies
Eligibility:
All Genders
6-15 years
Phase:
PHASE2
Brief Summary
Scabies is highly contagious,pruritic infestation of skin.Various treatment modalities have been used but search for ideal scabicide is ongoing.we wnt to coduct this study to compare the outcome of pe...
Eligibility Criteria
Inclusion
- Age 6-15
- Both genders
- Diagnosed with scabies (as per operational definition)
Exclusion
- Children with recurrent scabies on medical record
- Known allergy to ivermectin or permethrin.
- Widespread eczema or impetigo.
- Liver dysfunction or renal failure
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06896929
Start Date
May 1 2025
End Date
April 1 2026
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children Hospital Lahore
Lahore, Punjab Province, Pakistan